Armoda Tablet 150 mg is a wakefulness-promoting agent used primarily to treat sleep disorders characterized by excessive sleepiness. It is the R-enantiomer of modafinil, which means it is a more refined version of the same compound. Armoda Tablet 150 mg is known for its cognitive-enhancing properties and is used to improve wakefulness in patients with conditions such as narcolepsy, obstructive sleep apnea, and shift work disorder.
Armoda Tablet 150 mg is used for:
| Brand Name | Armoda |
|---|---|
| Type | Tablet |
| Weight | 150 mg |
| Generic | Armodafinil |
| Manufacturer | ACI Limited |
| Available in | English বাংলা |
Armoda Tablet 150 mg is believed to work by increasing the levels of certain neurotransmitters in the brain, including dopamine, norepinephrine, and histamine, which promote wakefulness and cognitive function. The exact mechanism of how it promotes wakefulness is not fully understood but is thought to involve the inhibition of dopamine reuptake.
Armoda Tablet 150 mg typically starts to work within 1 to 2 hours after oral administration. The peak effect is usually observed around 2-4 hours post-dose, with its wakefulness-promoting effects lasting up to 12-15 hours.
Armoda Tablet 150 mg is well absorbed from the gastrointestinal tract following oral administration. It reaches peak plasma concentrations within 2 hours, and its absorption is not significantly affected by food intake.
Armoda Tablet 150 mg is primarily metabolized by the liver and eliminated through the kidneys. Its metabolites are excreted in the urine, with a small portion also excreted in the feces.
The typical dosage for armodafinil is:
Armoda Tablet 150 mg is administered orally, usually in the form of tablets. It should be taken with a full glass of water, with or without food, and the dosage should be adhered to as prescribed by a healthcare provider.
Common side effects include:
Symptoms of armodafinil overdose may include severe headaches, nausea, agitation, and hallucinations. In cases of suspected overdose, seek immediate medical attention.
Precautions include:
Armoda Tablet 150 mg may interact with:
Use armodafinil with caution in individuals with:
Drug interactions may occur with:
Armoda Tablet 150 mg's absorption is not significantly affected by food, but it should be taken consistently in relation to meals to maintain steady drug levels in the body.
Armoda Tablet 150 mg should be used during pregnancy only if the potential benefits outweigh the risks. It is categorized as a Category C drug, meaning animal studies have shown adverse effects, but there are no well-controlled studies in pregnant women.
Armoda Tablet 150 mg is excreted in breast milk, and its effects on a nursing infant are unknown. Use with caution and consult a healthcare provider to discuss the risks and benefits before using it while breastfeeding.
In cases of acute overdose, symptoms may include severe agitation, insomnia, hallucinations, and cardiovascular symptoms. Immediate medical intervention is required to manage and treat the overdose effectively.
Armoda Tablet 150 mg is contraindicated in individuals with:
Follow the prescribed dosage instructions carefully. Take the tablet orally with a full glass of water, preferably in the morning for daytime sleep disorders, or approximately 1 hour before the shift for shift work disorder.
Store armodafinil at room temperature, away from moisture and direct sunlight. Keep out of reach of children and follow any additional storage instructions provided with the medication.
The volume of distribution for armodafinil is not explicitly detailed in standard references, but it is distributed throughout the body after oral administration.
The elimination half-life of armodafinil is approximately 12-15 hours, allowing for once-daily dosing.
Armoda Tablet 150 mg is cleared primarily through the liver, with its metabolites excreted in the urine. Clearance rates can vary based on individual metabolic rates and liver function.
See in details version Armoda Tablet 150 mg also Armoda Tablet 150 mg in bangla
Prof. Dr. Khandoker Ziaul Islam Zia
Glaucoma, Phaco, Laser & Vitreo-Retina Specialist Surgeon